Compounds of the formula: ##STR00001## or pharmaceutically acceptable
salts, solvates or prodrugs thereof, wherein Ar, R.sup.1 and R.sup.2 are
defined herein. Also provided are pharmaceutical compositions, methods of
preparing the compounds, and method of using the compounds for treatment
of monoamine reuptake inhibitor-mediated diseases.